Skip to main content

Table 2 Summary of the characteristics of included articles

From: Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals

Article summary

N

%

Number of patients

 ≤ 100

136

56.9

101 to 500

73

30.5

 ≥ 501

30

12.6

Age Range

Pediatric (< 18)

23

9.6

Adult (≥ 18)

187

78.2

Both

29

12.1

Type of QoL report

Self-reported

226

94.6

Proxy-reported

4

1.7

Both

9

3.8

Disease classification (ICD-11)

Neoplasms

7

2.9

Diseases of the blood or blood-forming organs

4

1.7

Diseases of the circulatory system

60

25.1

Diseases of the immune system

2

0.8

Endocrine, nutritional or metabolic diseases

5

2.1

Sleep–wake disorders

1

0.4

Diseases of the nervous system

18

7.4

Diseases of the visual system

58

24.3

Diseases of the respiratory system

3

1.3

Diseases of the digestive system

58

24.3

Diseases of the musculoskeletal system or connective tissue

15

6.3

Diseases of the urinary system

1

0.4

Developmental anomalies

1

0.4

Symptoms, signs, or clinical findings, not elsewhere classified

6

2.5

Total number of included articles

239

  1. The sum of the percentages might not yield 100% due to numerical rounding